Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals had revenue of $19.22M in the quarter ending June 30, 2025, with 33.34% growth. This brings the company's revenue in the last twelve months to $64.60M, up 30.14% year-over-year. In the year 2024, Recursion Pharmaceuticals had annual revenue of $58.84M with 32.00% growth.

• Revenue (ttm): $64.60M
• Revenue Growth: +30.14%
• P/S Ratio: 31.75
• Revenue / Employee: $80,745
• Employees: 800
• Market Cap: 2.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	58.84M	14.26M	32.00%
Dec 31, 2023	44.58M	4.73M	11.88%
Dec 31, 2022	39.84M	29.67M	291.46%
Dec 31, 2021	10.18M	6.22M	156.89%
Dec 31, 2020	3.96M	1.64M	70.85%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.